Diovan effectiveness in combined treatment of severe arterial hypertension

被引:0
作者
Bichan, NA [1 ]
Maslov, AP [1 ]
机构
[1] Novokuznetsk Adv Med Training Inst, Dept Therapy, Novokuznetsk, Russia
关键词
diovan; severe arterial hypertension; combined treatment;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aim, To assess effectiveness of diovan, a novel angiotensin-II antagonist, in combined hypotensive treatment of patients with severe arterial hypertension. Material and methods, 15 patients with severe arterial hypertension received diovan in a dose 80-160 mg/day for 8 weeks in combination with clofelin, beta-adrenoblockers, ACE inhibitors, diuretics prescribed before the start of diovan. Diovan effects were studied by 24-h monitoring of arterial pressure, tolerance, changes in blood counts, central hemodynamics. Results, Adjuvant hypotensive treatment with diovan lowered arterial pressure to satisfactory levels in 80% of patients. 13.3% did not respond to diovan. 6.7% of patients were withdrawn because of allergy. Only 2 patients of those who completed the diovan course developed side effects in first two weeks of the treatment - they had head ache. Conclusion. Diovan is effective in combination with clofelin, ACE inhibitors, diuretics, beta-adrenoblockers.
引用
收藏
页码:34 / 36
页数:3
相关论文
共 4 条
  • [1] Valsartan - A review of its pharmacology and therapeutic use in essential hypertension
    Markham, A
    Goa, KL
    [J]. DRUGS, 1997, 54 (02) : 299 - 311
  • [2] ODDOUSTOCK P, 1997, AM J HYPERTENS, V10, pA84
  • [3] The efficacy and safety of valsartan compared with placebo in the treatment of patients with essential hypertension
    Oparil, S
    Dyke, S
    Harris, F
    Kief, J
    James, D
    Hester, A
    Fitzsimmons, S
    [J]. CLINICAL THERAPEUTICS, 1996, 18 (05) : 797 - 810
  • [4] 1997, NOVARTIS PHARMA AG